Drug Trial Radar · NCT06765668
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Last checked: Nov 20, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Feb 12, 2025
Primary completion
Nov 2025
Study completion Aug 6, 2026
Sponsor
- Lead sponsor
- Impax Laboratories, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Amneal Pharmaceuticals, LLC
- First posted
- Jan 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).
Conditions
- Parkinson Disease
Interventions
CREXONT ERDrug
CREXONT ER capsule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in "GOOD ON" time per the Parkinson's Disease Diary to Day 42Time frame: Baseline, Day 42
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona · Not yet recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
Parkinson's Research Centers of America - Orange County
Aliso Viejo, California · Recruiting
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California · Recruiting
Visionary Investigators Network
Aventura, Florida · Recruiting
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida · Recruiting
Univesity of Miami - Miller School of Medicine
Boca Raton, Florida · Recruiting
University of Miami
Miami, Florida · Recruiting
N1 Research LLC
Orlando, Florida · Recruiting
USF Parkinson's Disease and Movement Disorders Center
Tampa, Florida · Recruiting
Central DuPage Hospital - Movement Disorders Center
Winfield, Illinois · Not yet recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Quest Research Institute
Farmington Hills, Michigan · Recruiting
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada · Not yet recruiting
Parkinson's Research Centers of America - Long Island
Commack, New York · Recruiting
Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower
Winston-Salem, North Carolina · Recruiting
NeuroScience Research Center, LLC
Canton, Ohio · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma · Recruiting
Neurology Consultants of Dallas, PA
Dallas, Texas · Recruiting
Texas Movement Disorder Specialists, PLLC
Georgetown, Texas · Recruiting
Icahn School of Medicine at Mount Sinai
Houston, Texas · Not yet recruiting
The University of Texas Health Science Center at Houston- McGovern Medical School
Houston, Texas · Recruiting
Inova Neurology
Fairfax, Virginia · Recruiting
VCU Parkinsons Disease and Movement Disorders Center
Henrico, Virginia · Recruiting
MedStar Georgetown University Hospital Department of Neurology
McLean, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.